TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BBBY

Bed Bath & Beyond, Inc.

— · —

3.40$ -14.7% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Stock Watch

Stock Watch will tell you what changes at Bed Bath & Beyond, Inc..

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 3.70 $ to 12.10 $ · Last price: 3.40 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 0.3$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 58m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. –
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. –

Performance

Perf. 1M ?Price performance over the last month. -6.40%
Perf. 3M ?Price performance over the last 3 months. 37.50%
Perf. 6M ?Price performance over the last 6 months. 7.30%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 21.10%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -50.1%
Perf. 1Y ?Price performance over the last 12 months. -54.91%
Perf. 3Y ?Price performance over the last 3 years. -85.12%
Perf. 5Y ?Price performance over the last 5 years. -94.32%
Perf. 10Y ?Price performance over the last 10 years. -69.88%
Perf. Since Inception ?Price performance since the first available trading day (05/30/2002) — with a complete history, that is since the IPO. -64.25%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 4.60$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 4.80$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 5.40$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 39.6
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 76.5%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 74.4%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. –
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 12.9
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. 1.9
P/B ?Price-to-book ratio: market value relative to book equity. 1.5
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 0.3
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 42.3
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. –

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. –
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. –
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 0.0%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 0.0%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 0.0%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. –
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. 0.1
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. warning zone -3.52
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 5 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). –
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. -25.12%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 14.02%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. 56.00%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 3
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 52
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 50
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. C (47 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 1,800 $M 2016 · Operating income: -13 $M 2016 · Net income: 13 $M 2017 · Revenue: 1,745 $M 2017 · Operating income: -47 $M 2017 · Net income: -113 $M 2018 · Revenue: 1,822 $M 2018 · Operating income: -215 $M 2018 · Net income: -207 $M 2019 · Revenue: 1,459 $M 2019 · Operating income: -125 $M 2019 · Net income: -120 $M 2020 · Revenue: 2,494 $M 2020 · Operating income: 97 $M 2020 · Net income: 52 $M 2021 · Revenue: 2,756 $M 2021 · Operating income: 111 $M 2021 · Net income: 109 $M 2022 · Revenue: 1,929 $M 2022 · Operating income: 27 $M 2022 · Net income: -35 $M 2023 · Revenue: 1,561 $M 2023 · Operating income: -118 $M 2023 · Net income: -308 $M 2024 · Revenue: 1,395 $M 2024 · Operating income: -191 $M 2024 · Net income: -259 $M 2025 · Revenue: 1,045 $M 2025 · Operating income: -61 $M 2025 · Net income: -85 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 1,800 -13 13 0.49 1,042 2,719 6,846
2017 1,745 -47 -113 -4.51 860 2,889 7,041
2018 1,822 -215 -207 -6.92 918 132 461
2019 1,459 -125 -120 -3.45 -82 115 418
2020 2,494 97 52 1.26 196 374 830
2021 2,756 111 109 2.51 81 744 1,066
2022 1,929 27 -35 -0.80 -991 646 879
2023 1,561 -118 -308 -6.81 -19 359 636
2024 1,395 -191 -259 -5.56 -174 163 402
2025 1,045 -61 -85 -1.41 -57 218 425

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 303.2 $M Q4 2025: Q1 · 231.7 $M Q1 2025: Q2 · 282.3 $M Q2 2025: Q3 · 257.2 $M Q3 2025: Q4 · 273.4 $M Q4 2026: Q1 · 247.8 $M Q1 2026: Q2 · 361.2 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -1.66 – 303 -21.10 -26.80 -22 -25
2025: Q1 -0.74 – 232 -39.40 -17.20 -51 -57
2025: Q2 -0.34 – 282 -29.10 -6.80 16 14
2025: Q3 -0.07 – 257 -17.40 -1.80 -15 -27
2025: Q4 -0.30 – 273 -9.80 -7.60 -7 -9
2026: Q1 -0.24 – 248 6.90 -6.60 -12 -13
2026: Q2 -0.53 -55.90 361 27.90 -10.90 -38 -42

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 3 of our scanner strategies — each hit links to the scanner.

Breakout & Setup

Momentum & Trend

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus –
Analyst Ratings –
Price Target (average) 10.25$
Distance to price 201.5% The price target sits 201.5% above the current price.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 -1.31 -1.51 – -0.92 1,709 -36.6% 3
12/31/2027 -0.08 -0.20 – 0.01 2,339 94.0% 3

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.

How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

3 of 10 Weak growth
  • Revenue grows by more than 15% a year over three years -18.5%
  • More than 10% revenue growth is expected for the coming year 14.0%
  • Share count grows by less than 3% a year 10.7%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -32.7%
  • Gross margin at 40% or higher and without meaningful erosion 24.7%
  • Goodwill from acquisitions does not grow faster than revenue 1.5%
  • Net debt below twice EBITDA 153 m net cash
  • Operating cash flow covers the profits of the last three years 402 m
  • Return on capital at 15% or higher, or up versus two years ago -26.2%
  • Insiders hold at least 10% or are net buyers 0.0%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

4/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% -5.9%
  • Exp. sales growth 3Y > 5% 49.6%
  • EBIT growth 10Y > 5% –
  • Exp. EBIT growth 3Y > 5% 49.6%
  • Net debt < 4x EBIT –
  • EBIT positive, 10Y straight 3
  • Max. EBIT decline < 50% 100.0%
  • Return on equity > 15% -50.9%
  • ROCE > 15% -26.2%
  • Expected return > 10% 14.0%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Aug 12, 2026 Lemonis Marcus EXECUTIVE CHAIRMAN & CEO Buy 23,094 4.30 99,304
Aug 6, 2026 Shapiro Robert Jacob Director Buy 3,000 4.51 13,530
Aug 6, 2026 Tabacco Joseph J Jr Director Buy 20,000 4.57 91,400
Aug 5, 2026 Lemonis Marcus EXECUTIVE CHAIRMAN & CEO Buy 43,382 4.67 202,594

View all insider transactions →

The company

About the Company

NA

IPO Date
05/30/2002
ISIN
US6903701018
Stock Split
2:1 on 08/14/2000
Stock Split
2:1 on 08/03/1998
Stock Split
2:1 on 05/01/1996

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 08/14/2026 NEIGHBORHOOD INTELLIGENCE, INC. (BBBY): Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Other Events; Financial Statements and Exhibits SEC ↗
  • 08/13/2026 BED BATH & BEYOND, INC. (BBBY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers SEC ↗
  • 08/05/2026 BED BATH & BEYOND, INC. (BBBY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events; Financial Statements and Exhibits SEC ↗
  • 08/04/2026 BED BATH & BEYOND, INC. (BBBY): Other Events; Financial Statements and Exhibits SEC ↗
  • 08/04/2026 BED BATH & BEYOND, INC. (BBBY): Other Events SEC ↗
  • 08/04/2026 BED BATH & BEYOND, INC. (BBBY): Results of Operations and Financial Condition; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
  • 07/27/2026 BED BATH & BEYOND, INC. (BBBY): Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Statements and Exhibits SEC ↗
  • 07/09/2026 BED BATH & BEYOND, INC. (BBBY): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?